Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'GARBE C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 124 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schittek, B; Hipfel, R; Sauer, B; Bauer, J; Kalbacher, H; Stevanovic, S; Schirle, M; Schroeder, K; Blin, N; Meier, F; Rassner, G; Garbe, C
      Dermcidin: a novel human antibiotic peptide secreted by sweat glands

      NATURE IMMUNOLOGY
    2. Garbe, C; Blum, A
      Epidemiology of cutaneous melanoma in Germany and worldwide

      SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    3. Bauer, J; Blum, A; Sonnichsen, K; Metzler, G; Rassner, G; Garbe, C
      Nodular scabies detected by computed dermatoscopy

      DERMATOLOGY
    4. Blum, A; Metzler, G; Bauer, J; Rassner, G; Garbe, C
      The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris

      DERMATOLOGY
    5. Blaheta, HJ; Metzler, G; Rassner, G; Garbe, C
      Hyperkeratosis lenticularis perstans (Flegel's disease) - Lack of responseto treatment with tacalcitol and carcipotriol

      DERMATOLOGY
    6. Blaheta, HJ; Sotlar, K; Breuninger, H; Bueltmann, B; Rassner, G; Garbe, C; Horny, HP
      Does intensive histopathological workup by serial sectioning increase the detection of lymph node micrometastasis in patients with primary cutaneous melanoma?

      MELANOMA RESEARCH
    7. Reinhold, U; Berkin, C; Bosserhoff, AK; Deutschmann, A; Garbe, C; Glaser, R; Hein, R; Krahn, G; Peter, RU; Rappl, G; Schittek, B; Seiter, S; Ugurel, S; Volkenandt, M; Tilgen, W
      Interlaboratory evaluation of a new reverse transcriptase polymerase chainreaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: A multicenter study of the dermatologic cooperativeoncology group

      JOURNAL OF CLINICAL ONCOLOGY
    8. Lang, KS; Caroli, CC; Muhm, A; Wernet, D; Moris, A; Schittek, B; Knauss-Scherwitz, E; Stevanovic, S; Rammensee, HG; Garbe, C
      HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    9. Reich, K; Garbe, C; Blaschke, V; Maurer, C; Middel, P; Westphal, G; Lippert, U; Neumann, C
      Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    10. Garbe, C
      Differential diagnosis of pigmented skin changes and the treatment of melanoma of the lower genital tract in women

      GYNAKOLOGE
    11. Blaheta, HJ; Paul, T; Sotlar, K; Maczey, E; Schittek, B; Paul, A; Moehrle, M; Breuninger, H; Bueltmann, B; Rassner, G; Garbe, C
      Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness

      BRITISH JOURNAL OF DERMATOLOGY
    12. Paul, T; Radny, P; Krober, SM; Paul, A; Blaheta, HJ; Garbe, C
      Intralesional rituximab for cutaneous B-cell lymphoma

      BRITISH JOURNAL OF DERMATOLOGY
    13. Fuhrmann, D; Lippold, A; Borrosch, F; Ellwanger, U; Garbe, C; Suter, L
      Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas?

      BRITISH JOURNAL OF DERMATOLOGY
    14. Hauschild, A; Garbe, C; Stolz, W; Ellwanger, U; Seiter, S; Dummer, R; Ugurel, S; Sebastian, G; Nashan, D; Linse, R; Achtelik, W; Mohr, P; Kaufmann, R; Fey, M; Ulrich, J; Tilgen, W
      Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)

      BRITISH JOURNAL OF CANCER
    15. Bauer, J; Metzler, G; Rassner, G; Garbe, C; Blum, A
      Dermatoscopy turns histopathologist's attention to the suspicious area in melanocytic lesions

      ARCHIVES OF DERMATOLOGY
    16. Moehrle, M; Dennenmoser, B; Schlagenhauff, B; Thomma, S; Garbe, C
      High prevalence of seborrhoeic dermatitis on the pace and scalp in mountain guides

      DERMATOLOGY
    17. Moehrle, M; Heinrich, L; Schmid, A; Garbe, C
      Extreme UV exposure of professional cyclists

      DERMATOLOGY
    18. Moehrle, M; Garbe, C
      Solar UV-protective properties of textiles

      DERMATOLOGY
    19. Moehrle, M; Garbe, C
      Personal UV dosimetry by Bacillus subtilis spore films

      DERMATOLOGY
    20. Schlagenhauff, B; Schittek, B; Ellwanger, U; Stroebel, W; Blum, A; Schwarz, M; Rassner, G; Garbe, C
      Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence?

      MELANOMA RESEARCH
    21. Schlagenhauff, B; Ellwanger, U; Breuninger, H; Stroebel, W; Rassner, C; Garbe, C
      Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma

      MELANOMA RESEARCH
    22. Moehrle, M; Korn, M; Garbe, C
      Bacillus subtilis spare film dosimeters in personal dosimetry for occupational solar ultraviolet exposure

      INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
    23. Schaumburg-Lever, G; Lever, I; Fehrenbacher, B; Moller, H; Bischof, B; Kaiserling, E; Garbe, C; Rassner, G
      Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy

      JOURNAL OF CUTANEOUS PATHOLOGY
    24. Garbe, C; Buettner, PG
      Predictors of the use of sunscreen in dermatological patients in central Europe

      PREVENTIVE MEDICINE
    25. Blaheta, HJ; Ellwanger, U; Schittek, B; Sotlar, K; Maczey, E; Breuninger, H; Thelen, MH; Bueltmann, B; Rassner, G; Garbe, C
      Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    26. Garbe, C
      Evaluation of education measures on the prophylaxis of malignant melanoma

      HAUTARZT
    27. Breuninger, H; Garbe, C; Rassner, G
      Shave excision of cutaneous melanocytic nevi. Indications, technique, results

      HAUTARZT
    28. Garbe, C
      Increasing frequency of malignant melanoma

      HAUTARZT
    29. Garbe, C; McLeod, GRC; Buettner, PG
      Time trends of cutaneous melanoma in Queensland, Australia and Central Europe

      CANCER
    30. Blum, A; Schlagenhauff, B; Stroebel, W; Breuninger, H; Rassner, G; Garbe, C
      Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma - Results of a prospective study of 1288 patients

      CANCER
    31. Weide, B; Schittek, B; Klyscz, T; Schuz, K; Stark, M; Rassner, G; Wilske, B; Garbe, C
      Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction

      BRITISH JOURNAL OF DERMATOLOGY
    32. Kuchelmeister, C; Schaumburg-Lever, G; Garbe, C
      Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients

      BRITISH JOURNAL OF DERMATOLOGY
    33. Weide, B; Walz, T; Garbe, C
      Is morphoea caused by Borrelia burgdorferi? A review

      BRITISH JOURNAL OF DERMATOLOGY
    34. Hipfel, R; Schittek, B; Bodingbauer, Y; Garbe, C
      Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization

      BRITISH JOURNAL OF CANCER
    35. Meier, F; Nesbit, M; Hsu, MY; Martin, B; Van Belle, P; Elder, DE; Schaumburg-Lever, G; Garbe, C; Walz, TM; Donatien, P; Crombleholme, TM; Herlyn, M
      Human melanoma progression in skin reconstructs - Biological significance of bFGF

      AMERICAN JOURNAL OF PATHOLOGY
    36. Buettner, PG; Garbe, C
      Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    37. Hauschild, A; Volkenandt, M; Garbe, C
      Adjuvant drug treatment of malignant melanoma

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    38. Moehrle, M; Garbe, C
      Does mountaineering increase the incidence of cutaneous melanoma? A hypothesis based on cancer registry data

      DERMATOLOGY
    39. Blaheta, HJ; Schittek, B; Breuninger, H; Sotlar, K; Ellwanger, U; Thelen, MH; Maczey, E; Rassner, G; Bueltmann, B; Garbe, C
      Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    40. Schittek, B; Sauer, B; Garbe, C
      Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines

      INTERNATIONAL JOURNAL OF CANCER
    41. Becker, J; Brocker, EB; Dummer, R; Enk, A; Garbe, C; Hauschild, A; Hein, R; Kaufmann, R; Krahn, G; Lohmann, F; Luther, H; Mauch, C; Mohr, P; Nashan, D; Neuber, K; Peter, RU; Reinhold, U; Schadendorf, D; Sebastian, G; Soyer, P; Stadler, R; Stolz, W; Tilgen, W; Trefzer, U; Tronnier, M; Ulrich, J; Volkenandt, M
      Current position of the Working Group on Dermatological Oncology on high-dose therapy with interferon alpha 2b

      HAUTARZT
    42. Blum, A; Brand, CU; Ellwanger, U; Schlagenhauff, B; Stroebel, W; Rassner, G; Garbe, C
      Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment

      BRITISH JOURNAL OF DERMATOLOGY
    43. Schittek, B; Bodingbauer, Y; Ellwanger, U; Blaheta, HJ; Garbe, C
      Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma

      BRITISH JOURNAL OF DERMATOLOGY
    44. Schittek, B; Blaheta, HJ; Florchinger, G; Sauer, B; Garbe, C
      Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction

      BRITISH JOURNAL OF DERMATOLOGY
    45. BRAND CU; BLUM A; SCHLEGEL A; FARIN G; GARBE C
      APPLICATION OF ARGON PLASMA COAGULATION IN SKIN SURGERY

      Dermatology
    46. HUSAK R; GARBE C; ORFANOS CE
      ORAL HAIRY LEUKOPLAKIA IN HIV-POSITIVE PATIENTS - REPLY

      Journal of the American Academy of Dermatology
    47. Hipfel, R; Garbe, C; Schittek, B
      RNA isolation from human skin tissues for colorimetric differential display

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    48. ASTORI G; LAVERGNE D; BENTON C; HOCKMAYR B; EGAWA K; GARBE C; DEVILLIERS EM
      HUMAN PAPILLOMAVIRUSES ARE COMMONLY FOUND IN NORMAL SKIN OF IMMUNOCOMPETENT HOSTS

      Journal of investigative dermatology
    49. GARBE C
      LESSONS FROM THE GERMAN MELANOMA REGISTRY

      Journal of investigative dermatology
    50. MOEHRLE M; GARBE C
      PERSONAL UV-DOSIMETRY OF MOUNTAIN GUIDES BY BACILLUS-SUBTILIS SPORE FILMS

      Journal of investigative dermatology
    51. SCHLAGENHAUFF B; ELLWANGER U; STROEBEL W; RASSNER G; GARBE C
      ADDITIONAL PROGNOSTIC-SIGNIFICANCE OF HORIZONTAL TUMOR DIAMETER - AN EVALUATION OF PATIENTS OF THE GERMAN CENTRAL MELANOMA REGISTRY

      Journal of investigative dermatology
    52. ELLWANGER U; SCHLAGENHAUFF B; STROEBEL W; GARBE C
      RISK OF RECURRENCE AND DEATH IN CUTANEOUS MELANOMA - NO-RISK OR MAXIMUM RISK GROUPS CANNOT BE DEFINED BY TUMOR THICKNESS

      Journal of investigative dermatology
    53. BLAHETA HJ; SCHITTEK B; SOTLAR K; BREUNINGER H; THELEN MH; ELLWANGER U; GARBE C
      DETECTION OF MICROMETASTASES BY SENTINEL LYMPH-NODE DISSECTION AND RT-PCR IN PATIENTS WITH CUTANEOUS MELANOMA

      Journal of investigative dermatology
    54. SCHITTEK B; BLAHETA HJ; GARBE C
      AMPLIFICATION OF MELAN-A IN ADDITION TO TYROSINASE RESULTS IN A HIGHER SENSITIVITY FOR THE DETECTION OF TUMOR-CELLS IN PERIPHERAL-BLOOD OF MELANOMA PATIENTS

      Journal of investigative dermatology
    55. Reich, K; Bruck, M; Grafe, A; Vente, C; Neumann, C; Garbe, C
      Treatment of psoriasis with interleukin-10

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    56. BLAHETA HJ; SCHITTEK B; BREUNINGER H; MACZEY E; KROEBER S; SOTLAR K; ELLWANGER U; THELEN MH; RASSNER G; BULTMANN B; GARBE C
      LYMPH-NODE MICROMETASTASES OF CUTANEOUS MELANOMA - INCREASED SENSITIVITY OF MOLECULAR DIAGNOSIS IN COMPARISON TO IMMUNOHISTOCHEMISTRY

      International journal of cancer
    57. HAUSCHILD A; DUMMER R; GARBE C; KAUFMANN R; SCHADENDORF D; SOYER HP; STADLER R; TILGEN W
      ADJUVANT INTERFERON-ALPHA THERAPY FOR MEL ANOMA - STATEMENT BY THE DERMATOLOGICAL-ONCOLOGY-STUDY-GROUP (ADO)

      Hautarzt
    58. GARBE C; REUSCH M; BREUNINGER H; DUMMER R; HAUSCHILD A; KAUFMANN R; MENSING HO; MEYER; PANIZZON R; SCHMOCKEL C; SCHOFER H; SEBASTIAN G; SOYER HP; STERRY W; TILGEN W; VOLKENANDT M
      DIAGNOSTIC AND TREATMENT STANDARDS IN DERMATOLOGICAL ONCOLOGY

      Hautarzt
    59. Blum, A; Garbe, C; Rassner, G
      Prevention of malignant melanoma

      HAUTARZT
    60. SCHLAGENHAUFF B; MAASSEN MM; ZIMMERMANN C; ELLWANGER U; STROEBEL W; RASSNER G; GARBE C
      LOCALIZATION OF PRIMARY TUMOR CORRELATES SIGNIFICANTLY WITH THE PATTERN OF INITIAL METASTASIS IN MALIGNANT-MELANOMA

      British Journal of Cancer
    61. WELLNITZ U; POTSCH S; GARBE C; LASSMANN G
      INACTIVATION OF RIBONUCLEOTIDE REDUCTASE IN TUMOR-CELLS AND INHIBITION OF TUMOR-CELL GROWTH BY P-ALKOXYPHENOLS

      Melanoma research
    62. MILLER JG; GEE J; PRICE A; GARBE C; MACNEIL S
      INVESTIGATION OF ESTROGEN-RECEPTORS, SEX STEROIDS AND SOLUBLE ADHESION MOLECULES IN THE PROGRESSION OF MALIGNANT-MELANOMA

      Melanoma research
    63. BUETTNER P; GARBE C; GUGGENMOOSHOLZMANN I
      PROBLEMS IN DEFINING CUTOFF POINTS OF CONTINUOUS PROGNOSTIC FACTORS -EXAMPLE OF TUMOR THICKNESS IN PRIMARY CUTANEOUS MELANOMA

      Journal of clinical epidemiology
    64. BLAHETA HJ; SCHITTEK B; SOTLAR K; KROBER S; ELLWANGER U; GARBE C
      INCREASED SENSITIVITY FOR DETECTION OF LYMPH-NODE MICROMETASTASES IN MELANOMA USING MOLECULAR BIOLOGICAL TECHNIQUES

      Journal of investigative dermatology
    65. SCHITTEK B; FLORCHINGER G; BOCHENEK B; BLAHETA HJ; GARBE C
      OPTIMIZATION OF THE RT-PCR FOR THE DETECTION OF MELANOMA-CELLS IN PERIPHERAL-BLOOD

      Journal of investigative dermatology
    66. CARL M; STROEBEL W; RASSNER G; GARBE C
      DIFFICULTIES IN THE ULTRASOUND DIAGNOSIS OF LYMPH-NODE METASTASES IN CUTANEOUS MELANOMA WITH TUMOR-GROWTH

      Hautarzt
    67. HUSAK R; GARBE C; ORFANOS CE
      MOLLUSCA CONTAGIOSA IN HIV-PATIENTS - CLI NICAL MANIFESTATIONS, RELATION TO THE IMMUNOLOGICAL STATUS AND PROGNOSTIC-SIGNIFICANCE

      Hautarzt
    68. TRONNIER M; GARBE C; BROCKER EB; STADLER R; STEINKRAUS V; SOYER HP; WOLFF HH
      STANDARDS FOR THE HISTOPATHOLOGICAL DIAGN OSIS OF MALIGNANT-MELANOMA

      Hautarzt
    69. SCHLAGENHAUFF B; STROEBEL W; ELLWANGER U; MEIER F; ZIMMERMANN C; BREUNINGER H; RASSNER G; GARBE C
      METASTATIC MELANOMA OF UNKNOWN PRIMARY ORIGIN SHOWS PROGNOSTIC SIMILARITIES TO REGIONAL METASTATIC MELANOMA - RECOMMENDATIONS FOR INITIAL STAGING EXAMINATIONS

      Cancer
    70. BRAND CU; ELLWANGER U; STROEBEL W; MEIER F; SCHLAGENHAUFF B; RASSNER G; GARBE C
      PROLONGED SURVIVAL OF 2 YEARS OR LONGER FOR PATIENTS WITH DISSEMINATED MELANOMA - AN ANALYSIS OF RELATED PROGNOSTIC FACTORS

      Cancer
    71. BLUM A; ELLWANGER U; GARBE C
      SEASONAL PATTERNS IN THE DIAGNOSIS OF CUTANEOUS MALIGNANT-MELANOMA - ANALYSIS OF THE DATA OF THE GERMAN CENTRAL MALIGNANT-MELANOMA REGISTRY

      British journal of dermatology
    72. LUTHER H; GARBE C; ELLWANGER U; ALTMEYER P
      DEVELOPMENT OF MELANOCYTIC NEVI IN CHILDREN - REPLY

      Archives of dermatology
    73. BREITBART M; GARBE C; BUTTNER P; WEISS J; SOYER HP; STOCKER U; KRUGER S; BREITBART EW; WECKBECKER J; PANIZZON R; BAHMER F; TILGEN W; GUGGENMOOSHOLZMANN I; ORFANOS CE
      ULTRAVIOLET-LIGHT EXPOSURE, PIGMENTARY TRAITS AND THE DEVELOPMENT OF MELANOCYTIC NEVI AND CUTANEOUS MELANOMA - A CASE-CONTROL STUDY OF THE GERMAN CENTRAL MALIGNANT-MELANOMA REGISTRY

      Acta dermato-venereologica
    74. HAUSCHILD A; GARBE C; RADEMACHER D; CHRISTOPHERS E
      MERKEL CELL TUMORS OF THE SKIN

      Deutsche Medizinische Wochenschrift
    75. MAURER J; SCHLUMS D; KNOLLMANN FD; GARBE C; VOGL TJ; BIER J; FELIX R
      FAILURE OF GADOPENTETATE DIMEGLUMINE-ENHANCED, HIGH-RESOLUTION MAGNETIC-RESONANCE-IMAGING TO DIFFERENTIATE AMONG MELANIN-CONTAINING SKIN TUMORS

      Academic radiology
    76. KOOPS HS; GARBE C; HOHENBERGER P
      ISOLATED LIMB PERFUSION OF METASTATIC MALIGNANT-MELANOMA OF THE EXTREMITY WORTHWHILE

      European journal of cancer
    77. GARBE C
      ISOLATED LIMB PERFUSION OF METASTATIC MALIGNANT-MELANOMA OF THE EXTREMITY WORTHWHILE

      European journal of cancer
    78. HUSAK R; GARBE C; ORFANOS CE
      ORAL HAIRY LEUKOPLAKIA IN 71 HIV-SEROPOSITIVE PATIENTS - CLINICAL SYMPTOMS, RELATION TO IMMUNOLOGICAL STATUS, AND PROGNOSTIC-SIGNIFICANCE

      Journal of the American Academy of Dermatology
    79. LEPPLEWIENHUES A; BERWECK S; BOHMIG M; LEO CP; MEYLING B; GARBE C; WIEDERHOLT M
      K-MELANOMA CELL-PROLIFERATION( CHANNELS AND THE INTRACELLULAR CALCIUMSIGNAL IN HUMAN)

      The Journal of membrane biology
    80. KRASAGAKIS K; KRUGERKRASAGAKES S; THOLKE D; EBERLE J; VONDEROHE M; GARBE C; ORFANOS CE
      EXPRESSION AND EFFECTS OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) ISOFORMS ON PROLIFERATION OF NORMAL MELANOCYTES AND MELANOMA CELL-LINES IN-VITRO

      Journal of investigative dermatology
    81. GARBE C
      TREATMENT OF HYPERPIGMENTED PATCHES

      Hautarzt
    82. OWSIANOWSKI M; GARBE C; RAMAKER J; ORFANOS CE; GOLLNICK H
      THERAPEUTIC EXPERIENCE WITH EXTRACORPOREA L PHOTOPHORESIS - TECHNICALASPECTS, MONITORING AND CLINICAL-RESULTS IN 41 PATIENTS

      Hautarzt
    83. PETRES J; ROMPEL R; BUTTNER P; TEICHELMANN K; GARBE C
      ELECTIVE LYMPH-NODE DISSECTION IN PRIMARY MALIGNANT-MELANOMA

      Hautarzt
    84. GARBE C
      PROLONGED SURVIVAL IN DISSEMINATED MELANOMA AND THE IMPACT OF THERAPY- ANALYSIS OF THE DISEASE COURSE IN 22 PATIENTS SURVIVING 2 YEARS ANDMORE

      Hautarzt
    85. KRASAGAKIS K; HETTMANNSPERGER U; TRAUTMANN C; TEBBE B; GARBE C
      PERSISTENT SCLEREDEMA OF BUSCHKE IN A DIABETIC - IMPROVEMENT WITH HIGH-DOSE PENICILLIN

      British journal of dermatology
    86. LUTHER H; ALTMEYER P; GARBE C; ELLWANGER U; JAHN S; HOFFMANN K; SEGERLING M
      INCREASE OF MELANOCYTIC NEVUS COUNTS IN CHILDREN DURING 5 YEARS OF FOLLOW-UP AND ANALYSIS OF ASSOCIATED FACTORS

      Archives of dermatology
    87. GARBIN F; ECKERT K; BUTTNER P; GARBE C; CZARNECKI J; MAURER HR
      THE INFLUENCE OF THE THYMIC PREPARATION THYMEX-L ON DEFICIENT ANTITUMOR-ACTIVITY OF MONOCYTES FROM MELANOMA PATIENTS IN-VITRO

      Oncology Reports
    88. ROMPEL R; GARBE C; BUTTNER P; TEICHELMANN K; PETRES J
      ELECTIVE LYMPH-NODE DISSECTION IN PRIMARY MALIGNANT-MELANOMA - A MATCHED-PAIR ANALYSIS

      Melanoma research
    89. EBERLE J; GARBE C; WANG NP; ORFANOS CE
      INCOMPLETE EXPRESSION OF THE TYROSINASE GENE FAMILY (TYROSINASE, TRP-1, AND TRP-2) IN HUMAN-MALIGNANT MELANOMA-CELLS IN-VITRO

      Pigment cell research
    90. EBERLE J; GARBE C; ORFANOS CE
      IDENTIFICATION OF GENES SPECIFICALLY REGULATED IN HUMAN-MELANOMA CELLS

      Archives of dermatological research
    91. KRASAGAKIS K; GARBE C; EBERLE J; ORFANOS CE
      TUMOR NECROSIS FACTORS AND SEVERAL INTERLEUKINS INHIBIT THE GROWTH AND MODULATE THE ANTIGEN EXPRESSION OF NORMAL HUMAN MELANOCYTES IN-VITRO

      Archives of dermatological research
    92. ECKERT K; GARBIN F; MAURER HR; BUTTNER P; GARBE C; CZARNECKI J
      PROTHYMOSIN ALPHA-1 MODULATES LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY AND IL-2 PRODUCTION BY PERIPHERAL-BLOOD LYMPHOCYTES FROM MELANOMA PATIENTS IN-VITRO

      International journal of immunopharmacology
    93. HUBNER B; ECKERT K; GARBE C; MAURER HR
      SYNERGISTIC INTERACTIONS BETWEEN INTERFERON-BETA AND CARBOPLATIN ON SK-MEL-28 HUMAN-MELANOMA CELL-GROWTH INHIBITION IN-VITRO

      Journal of cancer research and clinical oncology
    94. EBERLE J; GARBE C; WANG NP; ORFANOS CE
      PMEL17 SHOWS A SIMILAR REGULATION PATTERN LIKE OTHER PIGMENT GENES (TYROSINASE, TRP-1 AND TRP-2) IN NORMAL HUMAN MELANOCYTES AND MELANOMA-CELLS IN-VITRO

      Journal of investigative dermatology
    95. MAURER J; KNOLLMANN FD; SCHLUMS D; GARBE C; VOGL TJ; BIER J; FELIX R
      ROLE OF HIGH-RESOLUTION MAGNETIC-RESONANCE-IMAGING FOR DIFFERENTIATING MELANIN-CONTAINING SKIN TUMORS

      Investigative radiology
    96. RIEGER E; SOYER HP; GARBE C; BUTTNER P; KOFLER R; WEISS J; STOCKER U; KRUGER S; ROSER M; WECKBECKER J; PANIZZON R; BAHMER F; TILGEN W; KERL H; ORFANOS CE
      OVERALL AND SITE-SPECIFIC RISK OF MALIGNANT-MELANOMA ASSOCIATED WITH NEVUS COUNTS AT DIFFERENT BODY SITES - A MULTICENTER CASE-CONTROL STUDY OF THE GERMAN-CENTRAL-MALIGNANT-MELANOMA-REGISTRY

      International journal of cancer
    97. GARBE C
      RISK-FACTORS FOR DEVELOPMENT OF MALIGNANT -MELANOMA AND IDENTIFICATION OF PERSONS AT RISK IN GERMAN-SPEAKING COUNTRIES

      Hautarzt
    98. GARBE C; BUTTNER P; ELLWANGER U; ORFANOS CE
      MANAGEMENT OF PRIMARY MALIGNANT-MELANOMA IN THE GERMAN-SPEAKING COUNTRIES DURING THE YEARS 1983 TO 1993 - A STUDY OF THE CENTRAL MALIGNANT-MELANOMA REGISTRY OF THE GERMAN DERMATOLOGICAL SOCIETY

      Hautarzt
    99. GARBE C; BUTTNER P; ELLWANGER U; BROCKER EB; JUNG EG; ORFANOS CE; RASSNER G; WOLFF HH
      THE CENTRAL MALIGNANT-MELANOMA REGISTRY O F THE GERMAN-DERMATOLOGICAL-SOCIETY 1983 TO 1993 - EPIDEMIOLOGIC TRENDS AND CURRENT TREATMENT OF CUTANEOUS MELANOMA

      Hautarzt
    100. GARBE C; BUTTNER P; BERTZ J; BURG G; DHOEDT B; DREPPER H; GUGGENMOOSHOLZMANN I; LECHNER W; LIPPOLD A; ORFANOS CE; PETERS A; RASSNER G; STADLER R; STROEBEL W
      PRIMARY CUTANEOUS MELANOMA - IDENTIFICATION OF PROGNOSTIC GROUPS AND ESTIMATION OF INDIVIDUAL PROGNOSIS FOR 5093 PATIENTS

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/21 alle ore 19:33:28